|
| Press Releases |
|
 |
|
| Wednesday, May 9, 2018 |
|
|
Helsinn Group announces the launch of the IV formulation of AKYNZEO(R) (fosnetupitant/palonosetron) in the United States |
| Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the intravenous formulation of AKYNZEO(R) (a fixed antiemetic combination of fosnetupitant, 235mg, and palonosetron, 0.25mg) for injection has been launched in the United States by its U.S. subsidiary, Helsinn Therapeutics (U.S.), Inc.. more info >> |
|
| Friday, April 20, 2018 |
|
|
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO(R) (fosnetupitant/ palonosetron) in the United States |
| Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the U.S. Food and Drug Administration (FDA) has approved the intravenous formulation of AKYNZEO(R) (NEPA, a fixed antiemetic combination of fosnetupitant, 235mg, and palonosetron, 0.25mg) as an alternative treatment option for patients experiencing CINV. more info >> |
|
| Tuesday, April 17, 2018 |
|
|
Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy |
| Taiho Pharmaceutical Co., Ltd., a Japanese R&D-driven specialty pharma focused on oncology and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announce that they are collaborating on the development of an investigational highly-selective RET inhibitor TAS0286/HM05, being evaluated in non-small cell lung cancer and other carcinomas. more info >> |
|
| Wednesday, March 28, 2018 |
|
|
Helsinn Healthcare S.A.: Winners of the inaugural Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced |
| Lyfebulb, a patient empowerment platform that connects patients, industry and investors to support user-driven innovation in chronic diseases, and Helsinn, with activities focused on early-stage investments in areas of high unmet patient need, today announced that Lorenzo Pradella of GreenBone Ortho, srl and Gitte Pedersen of Genomic Expression, Inc. have been chosen as winners of the first ever Lyfebulb-Helsinn Innovation Awards in Oncology. more info >> |
|
| Friday, March 2, 2018 |
|
|
Helsinn Healthcare S.A.: Eleven finalists have been chosen for the first ever Lyfebulb-Helsinn Innovation Summit & Award in Oncology |
| Lyfebulb, a patient empowerment platform that connects patients, industry and investors to support user-driven innovation in chronic diseases, and Helsinn, with activities focused on early-stage investments in areas of high unmet patient need, today announce the names of the eleven companies launched by patient entrepreneurs who are chosen as finalists for the Lyfebulb-Helsinn Innovation Summit & Award in Oncology. more info >> |
|
| Tuesday, October 17, 2017 |
|
|
Helsinn Pharmaceuticals (Beijing) Co. Ltd. Opens Office in Shanghai, China |
| Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces the approval of Helsinn Pharmaceuticals (Beijing) Co. Ltd., Shanghai branch, on August 7, 2017 by the Shanghai Administration for Industry and Commerce with a 30-year term. The full address and contact details of the Shanghai branch are found at the end of this announcement. more info >> |
|
| Friday, September 9, 2016 |
|
|
Helsinn and PatientsLikeMe Announce Results of NSCLC Patient Survey on Weight Loss |
| Helsinn Therapeutics (U.S.) Inc., the pharmaceutical group focused on building quality cancer care, and patient network PatientsLikeMe have unveiled findings from an online survey that captured experiences and insights about unintended weight loss and its burden among 95 patients living with non-small cell lung cancer. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
WPS AI 3.0 Launches to Strengthen Office Software Business
Aug 20, 2025 23:29: JST
|
|
|
Rust Mobile首次封閉測試定於11月開啟
Aug 20, 2025 23:00 HKT/SGT
|
|
|
Rust Mobile首次封闭测试定于11月开启
Aug 20, 2025 23:00 HKT/SGT
|
|
|
Rust Mobile's 1st Closed Beta Set for November
Aug 20, 2025 23:00 HKT/SGT
|
|
|
WPS AI 3.0 Launches to Strengthen Office Software Business
Aug 20, 2025 22:29 HKT/SGT
|
|
|
HKTDC Chairman promotes Hong Kong's business advantages in Thailand
Aug 20, 2025 22:10 HKT/SGT
|
|
|
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
Aug 20, 2025 21:30: JST
|
|
|
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
Aug 20, 2025 20:30 HKT/SGT
|
|
|
創新疫苗引擎持續驅動 康希諾開啟新增長週期
Aug 20, 2025 20:22 HKT/SGT
|
|
|
创新疫苗引擎持续驱动 康希诺开启新增长周期
Aug 20, 2025 20:02 HKT/SGT
|
|
|
Graphene Manufacturing Group Ltd. Announces Bought Public Offering of Units for Gross Proceeds of C$5 Million
Aug 20, 2025 19:59 HKT/SGT
|
|
|
Hengdeli Announces 2025 Interim Results
Aug 20, 2025 19:52 HKT/SGT
|
|
|
亨得利2025年中期業績發佈 堅持行穩致遠 保生存謀發展
Aug 20, 2025 19:52 HKT/SGT
|
|
|
Emperor W&J Announces 2025 Interim Results, Revenues from Hong Kong and Mainland China Increase by 9% Respectively
Aug 20, 2025 19:00 HKT/SGT
|
|
|
英皇鐘錶珠寶公佈2025年中期業績 來自香港及中國內地之收入分別上升9%
Aug 20, 2025 18:34 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
